Growth Metrics

Idexx Laboratories (IDXX) Total Non-Current Liabilities: 2009-2025

Historic Total Non-Current Liabilities for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $573.7 million.

  • Idexx Laboratories' Total Non-Current Liabilities fell 20.70% to $573.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $573.7 million, marking a year-over-year decrease of 20.70%. This contributed to the annual value of $630.2 million for FY2024, which is 23.50% down from last year.
  • Latest data reveals that Idexx Laboratories reported Total Non-Current Liabilities of $573.7 million as of Q3 2025, which was down 11.48% from $648.1 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Total Non-Current Liabilities registered a high of $1.0 billion during Q2 2021, and its lowest value of $573.7 million during Q3 2025.
  • In the last 3 years, Idexx Laboratories' Total Non-Current Liabilities had a median value of $723.5 million in 2024 and averaged $744.4 million.
  • Per our database at Business Quant, Idexx Laboratories' Total Non-Current Liabilities climbed by 7.65% in 2021 and then fell by 23.95% in 2025.
  • Idexx Laboratories' Total Non-Current Liabilities (Quarterly) stood at $983.6 million in 2021, then decreased by 8.28% to $902.2 million in 2022, then dropped by 8.69% to $823.8 million in 2023, then declined by 23.50% to $630.2 million in 2024, then decreased by 20.70% to $573.7 million in 2025.
  • Its Total Non-Current Liabilities was $573.7 million in Q3 2025, compared to $648.1 million in Q2 2025 and $629.5 million in Q1 2025.